Type
. Validity of the WHO operational classification and value of other clinical signs in the classification of leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2004;72(3):278-83. Available from: http://ila.ilsl.br/pdfs/v72n3a03.pdf
Type
. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2004;72(3):269-77. Available from: http://ila.ilsl.br/pdfs/v72n3a02.pdf
Type
. A rational approach to nasal reconstruction in leprosy. Plastic and reconstructive surgery. 2004;114(4):876-82; discussion 883-4.
Type
Special campaigns to eliminate leprosy: improving services. Weekly epidemiological record [Internet]. 2004;79(37):334-9. Available from: http://www.who.int/wer/2004/en/wer7937.pdf
Type
. The secret society. The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha. 2004;67(3):32-3.
Type
. Tumor necrosis factor production in patients with leprosy. Infection and immunity [Internet]. 1992;60(4):1441-6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC257016/pdf/iai00028-0191.pdf
Type
. Hansen and his discovery of Mycobacterium leprae. New Jersey medicine : the journal of the Medical Society of New Jersey. 1992;89(2):118-21.
Type
The original untouchables. New Jersey medicine : the journal of the Medical Society of New Jersey. 1992;89(2):111-2.
Type
. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (New York, N.Y.). 1992;255(5040):12.
Type
. Association of HLA antigens with differential responsiveness to Mycobacterium w vaccine in multibacillary leprosy patients. Journal of clinical immunology. 1992;12(1):50-5.